- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05198726
Speed of Processing (SoP) Training Plus α-tACS (aMCIUp)
Speed of Processing (SoP) Training Plus α-tACS in People With Mild Cognitive Impairment: a Double Blind, Parallel, Placebo Controlled Trial Study Protocol
Study Overview
Status
Intervention / Treatment
Detailed Description
Dementia is thought to affect 6.3 million people across Europe and is especially prevalent in people over 85 years old (23.7%). In this sense, several cognitive training programs, alone or in combination with non-invasive brain stimulation have been used in order to ameliorate age-related cognitive impairments, and even to act in a prophylactic manner in order to prevent more extreme deficits, such as the ones presented in mild cognitive impairment, or even dementia.
Despite all these efforts, the effects of CT - combined or not - with several forms of non-invasive brain stimulation have been modest at most.
The current proposal aims to assess if Speed of Processing (SoP) training combined with alpha tACS (α-tACS) increases speed of processing as assessed by the Useful Field of View (UFOV) when comparing to SoP training and sham α-tACS. Furthermore, association betweens changes in speed of processing and changes in other cognitive domains, such as memory, language and executive functioning will be assessed. Finnaly, the current proposal aims at probing the mechanisms underlying these interventions, namely to test brain connectivity and coherence as assessed by EEG.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Porto, Portugal, 4200 - 072
- Portucalense University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Community-dwelling adults aged 65 years and older, with cognitive complains in memory or other functions, which have declined over time
Exclusion Criteria:
- Score in the mini mental examination less than 23 (or over 28);
- Diagnosis of Alzheimer´s Disease, any other medical condition that may predispose participants for a forthcoming decline in function, or that may increase their risk of mortality during the duration of the study.
- Any contra-indication to tACS, severe sensory losses or communication difficulties that will prevent them from successfully complete the training.
- Had any cognitive training in the past.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Active tACS plus active SoP
Active alpha range tACS plus Speed of Processing Training
|
2mA α-tACS (based on the IAF) over the prefrontal cortex (PFC)
SoP training will have a total of four conditions.
In condition 1, participants will be asked to identity objects at increasingly brief exposures.
For condition 2, identification of stimulus on the center of the screen will be requested from participants, while a second stimulus will appear somewhere in peripheral vision - stimulus duration, difficulty of the central localization task or the area in which targets may be located are used to change the level of difficulty.
Condition 3 is similar to condition 2, but visual distractors are added.
Finally, for condition 4, an auditory identification component is superimposed over the visual task (Jobe et al., 2001)
|
|
Active Comparator: Active tACS plus sham SoP
Active alpha range tACS plus sham Speed of Processing Training
|
2mA α-tACS (based on the IAF) over the prefrontal cortex (PFC)
|
|
Active Comparator: Sham tACS plus active SoP
Sham alpha range tACS plus Speed of Processing Training
|
SoP training will have a total of four conditions.
In condition 1, participants will be asked to identity objects at increasingly brief exposures.
For condition 2, identification of stimulus on the center of the screen will be requested from participants, while a second stimulus will appear somewhere in peripheral vision - stimulus duration, difficulty of the central localization task or the area in which targets may be located are used to change the level of difficulty.
Condition 3 is similar to condition 2, but visual distractors are added.
Finally, for condition 4, an auditory identification component is superimposed over the visual task (Jobe et al., 2001)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Useful Field of View Test (UFOV)
Time Frame: Change from baseline to week 3
|
UFOV is a measure of the speed of visual processing for rapid detection and localization of targets under conditions of divided visual attention and in the presence and absence of visual clutter at an above chance level (i.e.
75%).
|
Change from baseline to week 3
|
|
Useful Field of View (UFOV)
Time Frame: Change from baseline to week 6
|
UFOV is a measure of the speed of visual processing for rapid detection and localization of targets under conditions of divided visual attention and in the presence and absence of visual clutter at an above chance level (i.e.
75%).
|
Change from baseline to week 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Executive Composite Score from the Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research (NIH EXAMINER)
Time Frame: Change from baseline to week 3
|
The NIH examiner executive composite comprises cognitive control, verbal fluency, and working memory assessments.
Scores are based on the Item Response theory (IRT), which allows for the contribution of each item score is weighted by how effective that item measures that ability in any part of the continuum.
Instead of a maximum or a minimum, higher scores, mean better performance.
|
Change from baseline to week 3
|
|
Executive Composite Score from the Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research (NIH EXAMINER)
Time Frame: Change from baseline to week 6
|
The NIH examiner executive composite comprises cognitive control, verbal fluency, and working memory assessments.
Scores are based on the Item Response theory (IRT), which allows for the contribution of each item score is weighted by how effective that item measures that ability in any part of the continuum.
Instead of a maximum or a minimum, higher scores, mean better performance.
|
Change from baseline to week 6
|
|
EEG power in the alpha band
Time Frame: Change from baseline to week 3
|
Total Power
|
Change from baseline to week 3
|
|
EEG power in the alpha band
Time Frame: Change from baseline to week 6
|
Total Power
|
Change from baseline to week 6
|
|
P300 Event related potential - A
Time Frame: Change from baseline to week 3
|
Amplitude of the P300 potential
|
Change from baseline to week 3
|
|
P300 Event related potential - L
Time Frame: Change from baseline to week 3
|
Latency of the P300 potential
|
Change from baseline to week 3
|
|
P300 Event related potential - A
Time Frame: Change from baseline to week 6
|
Amplitude of the P300 potential
|
Change from baseline to week 6
|
|
P300 Event related potential - L
Time Frame: Change from baseline to week 6
|
Latency of the P300 potential
|
Change from baseline to week 6
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Useful Field of View (UFOV)
Time Frame: Change from baseline to 1 month follow-up (after intervention ended)
|
Measure of the speed of visual processing for rapid detection and localization of targets under conditions of divided visual attention and in the presence and absence of visual clutter at an above chance level (i.e.
75%).
|
Change from baseline to 1 month follow-up (after intervention ended)
|
|
Useful Field of View (UFOV)
Time Frame: Change from baseline to 3 months follow-up (after intervention ended)
|
Measure of the speed of visual processing for rapid detection and localization of targets under conditions of divided visual attention and in the presence and absence of visual clutter at an above chance level (i.e.
75%).
|
Change from baseline to 3 months follow-up (after intervention ended)
|
|
Useful Field of View (UFOV)
Time Frame: Change from baseline to 6 months follow-up (after intervention ended)
|
Measure of the speed of visual processing for rapid detection and localization of targets under conditions of divided visual attention and in the presence and absence of visual clutter at an above chance level (i.e.
75%).
|
Change from baseline to 6 months follow-up (after intervention ended)
|
|
Executive Composite Score from NIH EXAMINER
Time Frame: Change from baseline to 1 month follow-up (after intervention ended)
|
The NIH examiner comprises cognitive control, verbal fluency, and working memory assessments
|
Change from baseline to 1 month follow-up (after intervention ended)
|
|
Executive Composite Score from NIH EXAMINER
Time Frame: Change from baseline to 3 months follow-up (after intervention ended)
|
The NIH examiner comprises cognitive control, verbal fluency, and working memory assessments
|
Change from baseline to 3 months follow-up (after intervention ended)
|
|
Executive Composite Score from NIH EXAMINER
Time Frame: Change from baseline to 6 months follow-up (after intervention ended)
|
The NIH examiner comprises cognitive control, verbal fluency, and working memory assessments
|
Change from baseline to 6 months follow-up (after intervention ended)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jorge Leite, PhD, Portucalense University
Publications and helpful links
General Publications
- Jobe JB, Smith DM, Ball K, Tennstedt SL, Marsiske M, Willis SL, Rebok GW, Morris JN, Helmers KF, Leveck MD, Kleinman K. ACTIVE: a cognitive intervention trial to promote independence in older adults. Control Clin Trials. 2001 Aug;22(4):453-79. doi: 10.1016/s0197-2456(01)00139-8.
- Leite J, Goncalves OF, Carvalho S. Speed of Processing (SoP) Training Plus alpha-tACS in People With Mild Cognitive Impairment: A Double Blind, Parallel, Placebo Controlled Trial Study Protocol. Front Aging Neurosci. 2022 Jul 14;14:880510. doi: 10.3389/fnagi.2022.880510. eCollection 2022.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UPT01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Dysfunction
-
Universidad Autónoma del Estado de HidalgoEnrolling by invitationCognitive Dysfunction ( MMSE < 24 )Mexico
-
Maria PaçoEnrolling by invitationDietary Supplements | Cognitive Dysfunction, Cognitive DisorderPortugal
-
Loma Linda UniversityCompleted1. Postoperative Cognitive DysfunctionUnited States
-
Mu Dong LiangNot yet recruitingPostoperative Cognitive Dysfunction(POCD)
-
HealthPartners InstituteCompletedPost Operative Cognitive DysfunctionUnited States
-
Burcu Ozalp HorsanaliCompletedPost Operative Cognitive Dysfunction
-
ImmunoChem Therapeutics, LLCNational Cancer Institute (NCI); Northwestern MedicineCompletedCognitive Dysfunction, Cognitive DisorderUnited States
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingPOCD - Postoperative Cognitive DysfunctionChina
-
Xijing HospitalFirst Affiliated Hospital Xi'an Jiaotong University; Shanghai 10th People's... and other collaboratorsTerminatedPost Operative Cognitive DysfunctionChina
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)CompletedPost Operative Cognitive DysfunctionUnited States
Clinical Trials on alpha tACS
-
Sebastian OlbrichNot yet recruitingSuicidal Ideation Active | Depression Disorders
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedMajor Depressive Disorder | MDDUnited States
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Schizoaffective DisorderUnited States
-
University of North Carolina, Chapel HillTerminatedDepression | Systemic Lupus ErythematosusUnited States
-
Boston University Charles River CampusNot yet recruitingAging | Memory | Noninvasive Brain Stimulation
-
Medipol UniversityEnrolling by invitationAttention Deficit Disorder With Hyperactivity (ADHD)Turkey (Türkiye)
-
Ke Dong, MDCompleted
-
The University of Texas Health Science Center,...Recruiting
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedLewy Body Disease | Dementia With Lewy BodiesItaly
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)Completed